Not Yet Recruiting
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
NCT07503353
- Conditions
- Acute Lymphobkastic Leukemia, B Cell Malignancies, Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)
- Locations
-
- Sheba Medical Center Ramat Gan, Israel